Salvia BioElectronics: Funding, Investors & Team (Sep 2026)
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are focused on developing a thin implant that can deliver gentle electrical pulses to nerves to reduce migraine symptoms. Through continued research and development, the company aims to advance its technology. With funding, they are working on bringing their migraine therapy to market to provide a different approach to pain management for patients, with a focus on improving patient outcomes using neuromodulation therapy.
Salvia BioElectronics has raised $60.0M across 1 funding round on record, the most recent a Series B of $60.0M announced in May 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Salvia BioElectronics Company Profile and Key Stats
Latest funding round on record: May 2025.
Salvia BioElectronics Funding Rounds
Salvia BioElectronics Founders and Leadership Team
No contact details are on record for this team yet.
Salvia BioElectronics Funding Compared to Other Biotechnology Startups
Salvia BioElectronics' latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Salvia BioElectronics in Biotechnology and Eindhoven
Companies Similar to Salvia BioElectronics
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and…
Salvia BioElectronics Funding FAQs
What does Salvia BioElectronics do?
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are focused on developing a thin implant that can deliver gentle electrical pulses to nerves to reduce migraine symptoms. Through continued research and development, the company aims to advance its technology. With funding, they are working on bringing their migraine therapy to market to provide a different approach to pain management for patients, with a focus on improving patient outcomes using neuromodulation therapy.
How much funding has Salvia BioElectronics raised?
Salvia BioElectronics has raised $60.0M across 1 round on record. The most recent is a Series B of $60.0M announced in May 2025.
When did Salvia BioElectronics last raise funding?
Salvia BioElectronics' most recent funding round on record is a Series B of $60.0M, announced in May 2025.
Who founded Salvia BioElectronics?
FundedIQ lists Hubert Martens (Founder) at Salvia BioElectronics.
Where is Salvia BioElectronics headquartered?
Salvia BioElectronics is based in Eindhoven, Noord-Brabant, Netherlands.
How many employees does Salvia BioElectronics have?
Salvia BioElectronics is in the 11-50 employee band.
How does Salvia BioElectronics' funding compare to other Biotechnology startups?
Salvia BioElectronics' latest round of $60.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Salvia BioElectronics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Salvia BioElectronics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.